VAS
Vestmark Advisory Solutions’s Bristol-Myers Squibb BMY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $297K | Sell |
6,420
-7,351
| -53% | -$340K | ﹤0.01% | 701 |
|
2025
Q1 | $840K | Buy |
13,771
+6,324
| +85% | +$386K | 0.02% | 427 |
|
2024
Q4 | $421K | Buy |
+7,447
| New | +$421K | 0.01% | 441 |
|
2023
Q3 | – | Sell |
-40,339
| Closed | -$2.58M | – | 472 |
|
2023
Q2 | $2.58M | Buy |
40,339
+4,090
| +11% | +$262K | 0.1% | 273 |
|
2023
Q1 | $2.51M | Buy |
36,249
+746
| +2% | +$51.7K | 0.11% | 261 |
|
2022
Q4 | $2.55M | Sell |
35,503
-651
| -2% | -$46.8K | 0.12% | 235 |
|
2022
Q3 | $2.57M | Buy |
36,154
+2,143
| +6% | +$152K | 0.14% | 201 |
|
2022
Q2 | $2.62M | Sell |
34,011
-2,797
| -8% | -$215K | 0.15% | 180 |
|
2022
Q1 | $2.69M | Sell |
36,808
-21,968
| -37% | -$1.6M | 0.15% | 166 |
|
2021
Q4 | $3.67M | Buy |
58,776
+2,712
| +5% | +$169K | 0.21% | 106 |
|
2021
Q3 | $3.32M | Buy |
56,064
+3,152
| +6% | +$186K | 0.22% | 108 |
|
2021
Q2 | $3.54M | Buy |
52,912
+3,620
| +7% | +$242K | 0.25% | 100 |
|
2021
Q1 | $3.11M | Sell |
49,292
-949
| -2% | -$59.9K | 0.28% | 94 |
|
2020
Q4 | $3.12M | Buy |
50,241
+6,974
| +16% | +$433K | 0.35% | 67 |
|
2020
Q3 | $2.61M | Buy |
43,267
+19,007
| +78% | +$1.15M | 0.35% | 70 |
|
2020
Q2 | $1.43M | Buy |
24,260
+5,082
| +26% | +$299K | 0.22% | 135 |
|
2020
Q1 | $1.07M | Sell |
19,178
-1,025
| -5% | -$57.1K | 0.21% | 154 |
|
2019
Q4 | $1.3M | Buy |
20,203
+9,150
| +83% | +$587K | 0.27% | 136 |
|
2019
Q3 | $560K | Buy |
11,053
+6,441
| +140% | +$326K | 0.09% | 270 |
|
2019
Q2 | $209K | Sell |
4,612
-3,054
| -40% | -$138K | 0.04% | 515 |
|
2019
Q1 | $366K | Buy |
+7,666
| New | +$366K | 0.07% | 343 |
|